CCM
TNDM icon

Coldstream Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

Coldstream Capital Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-6,651
Closed -$127K – 3164
2025
Q1 		$127K Buy
6,651
+466
+8% +$13.6K ﹤0.01% 1224
2024
Q4 		$223K Sell
6,185
-27
-0.4% -$913 ﹤0.01% 963
2024
Q3 		$263K Buy
6,212
+762
+14% +$32.3K 0.01% 903
2024
Q2 		$220K Buy
+5,450
New +$227K 0.01% 905
2022
Q1 		– Sell
-1,395
Closed -$210K – 860
2021
Q4 		$210K Buy
+1,395
New +$188K 0.01% 787

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Coldstream Capital Management's TNDM Position: Q2 2025 in Review

Coldstream Capital Management sold out of Tandem Diabetes Care (TNDM) in Q2 2025, closing a stake of 6,651 shares — an estimated $127K sold.

Coldstream Capital Management first reported a position in TNDM in Q4 2021 and held it in 5 quarters. The position peaked at $263K in Q3 2024. 270 funds tracked by Wall St. Rank hold TNDM as of Q2 2025.

  • Coldstream Capital Management reported no remaining Tandem Diabetes Care position as of Q2 2025 after selling out during the quarter.
  • Coldstream Capital Management sold 6,651 Tandem Diabetes Care shares in Q2 2025, an estimated $127K.
  • Coldstream Capital Management first reported a position in Tandem Diabetes Care in Q4 2021 and held it in 5 quarters.
  • Coldstream Capital Management's Tandem Diabetes Care position peaked at $263K in Q3 2024.
  • 270 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2025.

Based on Coldstream Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.